Immediate Impact

1 by Nobel laureates 2 from Science/Nature 54 standout
Sub-graph 1 of 25

Citing Papers

ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
2020 Standout
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
2018 Standout
2 intermediate papers

Works of Paul Baskind being referenced

Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults
1988
Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults
1988
and 1 more

Author Peers

Author Last Decade Papers Cites
Paul Baskind 342 173 171 186 25 506
Jassada Buaboonnam 267 136 158 165 27 546
P R Taylor 319 134 175 155 19 505
Silvia Manfroi 299 102 153 167 33 485
Laura N Eadie 366 171 101 116 35 519
ML Slovak 259 169 138 196 17 492
Fabio P S Santos 368 99 89 167 15 507
Mohamed Elhamri 301 150 100 177 42 481
Toshiya Yokozawa 219 98 107 275 17 517
L.R. Silverman 317 104 49 201 18 478
Marie Sébert 301 114 59 274 46 571

All Works

Loading papers...

Rankless by CCL
2026